| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444883 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
These findings suggest that low Dicer mRNA levels seem to be independent predictors of favourable outcome and response in patients affected by advanced CRCs treated with Bevacizumab-based therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bruno Vincenzi, Alice Zoccoli, Gaia Schiavon, Michele Iuliani, Francesco Pantano, Emanuela Dell'Aquila, Raffaele Ratta, Andrea Onetti Muda, Giuseppe Perrone, Chiara Brunelli, Pierpaolo Correale, Elisabetta Riva, Antonio Russo, Fotios Loupakis,